Drug General Information (ID: DDIEYTX6BA)
Drug Name			Tranylcypromine		Drug Info		Racepinephrine		Drug Info
Drug Type		Small molecule				Small molecule
Therapeutic Class		Antidepressants				Adrenergic Bronchodilators
Structure

Mechanism of Tranylcypromine-Racepinephrine Interaction (Severity Level: Moderate)
Additive hypertensive effects Click to Show/Hide Mechanism Graph
Drug Name		Tranylcypromine				Racepinephrine
Mechanism		Hypertensive effects				Hypertensive effects
Key Mechanism Factor 1
		Factor Name		Hypertensive effects
		Factor Description		Hypertension is defined as a blood pressure reading above a prescribed limit (130/90 mmHg). Most people with hypertension have no signs or symptoms; others may experience: severe headache, shortness of breath, nosebleeds, severe anxiety, and feeling a tingling sensation in the neck or head.
Mechanism Description		Additive hypertensive effects by the combination of Tranylcypromine and Racepinephrine

Recommended Action
Management		Cardiovascular status should be closely monitored when beta-2 agonists are coadministered with MAOIs or other agents that possess MAOI activity (e.g., furazolidone, linezolid, methylene blue, procarbazine). Preferably, at least 14 days should elapse between discontinuation of MAOI therapy and initiation of treatment with beta-2 agonists.

References
1	Adverse effects and complications of treatment with beta-adrenergic agonist drugs. Committee on drugs, the American Academy of Allergy and Immunology. J Allergy Clin Immunol 75 (1985): 443-9. [PMID: 2858503]
2	Boakes AJ, Laurence DR, Teoh PC, Barar FS, Benedikter LT, Prichard BN "Interactions between sympathomimetic amines and antidepressant agents in man." Br Med J 1 (1973): 311-5. [PMID: 4685619]
3	Darcy PF, Griffin JP "Interactions with drugs used in the treatment of depressive illness." Adverse Drug React Toxicol Rev 14 (1995): 211-31. [PMID: 8845455]
4	Finch JS "Cardiovascular toxicity: clinical evaluation of albuterol, isoproterenol and placebo in rising dose tolerance trial." Ann Allergy 47 (1981): 402-4. [PMID: 7030155]
5	Product Information. Alupent (metaproterenol). Boehringer-Ingelheim, Ridgefield, CT.
6	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
7	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
8	Product Information. Brethaire (terbutaline). Novartis Pharmaceuticals, East Hanover, NJ.
9	Product Information. Brovana (arformoterol). Sepracor Inc, Marlborough, MA.
10	Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
11	Product Information. Isuprel (isoproterenol). Sanofi Winthrop Pharmaceuticals, New York, NY.
12	Product Information. Maxair (pirbuterol). 3M Pharmaceuticals, St. Paul, MN.
13	Product Information. Proventil (albuterol). Schering Laboratories, Kenilworth, NJ.
14	Product Information. S2 Inhalant (racepinephrine). Nephron Pharmaceuticals, Orlando, FL.
15	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
16	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
17	Product Information. Tornalate Metered Dose (bitolterol). Dura Pharmaceuticals, San Diego, CA.
18	Product Information. Xopenex (levalbuterol). Sepracor, Marlborough, MA.